Labenz C - Search Results

1

Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study.

Gairing SJ, Mangini C, Zarantonello L, Jonasson E, Dobbermann H, Sultanik P, Galle PR, Labenz J, Thabut D, Marquardt JU, Bloom PP, Lauridsen MM, Montagnese S, Labenz C. Gairing SJ, et al. Among authors: labenz c. JHEP Rep. 2024 Apr 26;6(8):101104. doi: 10.1016/j.jhepr.2024.101104. eCollection 2024 Aug. JHEP Rep. 2024. PMID: 39035069 Free PMC article.

2

Keine Angst vor der Varizenligatur.

Labenz C. Labenz C. MMW Fortschr Med. 2021 Apr;163(7):24-26. doi: 10.1007/s15006-021-9831-9. MMW Fortschr Med. 2021. PMID: 33844211 Review. German. No abstract available.

3

Mit Gurkenbrühe gegen Muskelkrämpfe.

Labenz C. Labenz C. MMW Fortschr Med. 2022 Sep;164(15):29. doi: 10.1007/s15006-022-1884-x. MMW Fortschr Med. 2022. PMID: 36064910 Review. German. No abstract available.

4

Leberzirrhose: Patientinnen und Patienten überschätzen ihre Lebenserwartung.

Schleicher E, Labenz C. Schleicher E, et al. Among authors: labenz c. MMW Fortschr Med. 2023 May;165(10):29-31. doi: 10.1007/s15006-023-2682-9. MMW Fortschr Med. 2023. PMID: 37202686 Review. German. No abstract available.

5

[Chronic abdominal pain: these diseases can be the cause].

Labenz J, Labenz C, Gross M. Labenz J, et al. Among authors: labenz c. Dtsch Med Wochenschr. 2015 May;140(10):723-7. doi: 10.1055/s-0041-101711. Epub 2015 May 13. Dtsch Med Wochenschr. 2015. PMID: 25970410 German. No abstract available.

6

[Gastroenterological diseases as triggers of chest pain].

Labenz J, Labenz C. Labenz J, et al. Among authors: labenz c. Internist (Berl). 2017 Jan;58(1):29-38. doi: 10.1007/s00108-016-0164-1. Internist (Berl). 2017. PMID: 27921112 German.

7

Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib.

Labenz C, Prenosil V, Koch S, Huber Y, Marquardt JU, Schattenberg JM, Galle PR, Weinmann A, Wörns MA. Labenz C, et al. Dig Dis. 2018;36(1):78-88. doi: 10.1159/000477578. Epub 2017 Jul 4. Dig Dis. 2018. PMID: 28675895

8

Epidemiology of hepatic encephalopathy in german hospitals - the EpHE study.

Labenz C, Wörns MA, Schattenberg JM, Huber Y, Galle PR, Labenz J; ALGK study group. Labenz C, et al. Among authors: labenz j. Z Gastroenterol. 2017 Aug;55(8):741-747. doi: 10.1055/s-0043-114671. Epub 2017 Jul 12. Z Gastroenterol. 2017. PMID: 28701025 English.

9

Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.

Labenz C, Baron JS, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR, Wörns MA. Labenz C, et al. Aliment Pharmacol Ther. 2018 Aug;48(3):313-321. doi: 10.1111/apt.14824. Epub 2018 Jun 4. Aliment Pharmacol Ther. 2018. PMID: 29863286

10

Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort.

Huber Y, Bierling F, Labenz C, Koch S, Schmidtmann I, Kloeckner R, Schotten S, Huber T, Lang H, Woerns MA, Galle PR, Weinmann A, Weinmann-Menke J. Huber Y, et al. Among authors: labenz c. BMC Cancer. 2018 Jul 31;18(1):774. doi: 10.1186/s12885-018-4677-y. BMC Cancer. 2018. PMID: 30064393 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters